These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5001628)

  • 41. [Bacteriological and clinical aspects of the restoration of drug sensitivity of formerly resistant Mycobacterium cultures].
    Rudoĭ NM; Bochkov EN
    Probl Tuberk; 1973; 51(10):24-6. PubMed ID: 4206103
    [No Abstract]   [Full Text] [Related]  

  • 42. [The bacteriological principles of tuberculosis treatments].
    Grosset J
    Rev Prat; 1979 Jun; 29(33):2645-50. PubMed ID: 113863
    [No Abstract]   [Full Text] [Related]  

  • 43. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 44. Resistant tubercle bacilli.
    Lancet; 1972 Aug; 2(7774):412-3. PubMed ID: 4115230
    [No Abstract]   [Full Text] [Related]  

  • 45. Early results from indirect drug susceptibility test for tubercle bacilli.
    Mathew S; Narayanan A; Segaran R; Paramasivan CN
    Indian J Med Res; 1999 May; 109():167-9. PubMed ID: 10643140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance.
    Zykov MP; Donets JI; Poti SJ
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):40-56. PubMed ID: 4113512
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 49. Primary drug-resistant Mycobacterium tuberculosis isolated in Massachusetts in 1972.
    Stottmeier KD; Burkes J
    J Infect Dis; 1974 Sep; 130(3):293-294. PubMed ID: 4213310
    [No Abstract]   [Full Text] [Related]  

  • 50. Mode of action of anti-tubercular drugs.
    Santhanam K; Venkitasubramanian TA
    Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):192-207. PubMed ID: 96023
    [No Abstract]   [Full Text] [Related]  

  • 51. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 52. [Repeating of sensitivity tests with tuberculosis bacteria].
    Fodor T
    Prax Pneumol; 1971 Apr; 25(4):205-11. PubMed ID: 4995325
    [No Abstract]   [Full Text] [Related]  

  • 53. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

  • 54. Usefulness of E-test strips for testing susceptibility of Mycobacterium tuberculosis complex strains.
    Esteban J; Ortiz A; Jiménez MS
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):856-7. PubMed ID: 16315010
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug resistance and speed of growth of M. tuberculosis. I. Growth on drug-free medium.
    Zykov MP; Donets JI
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):35-9. PubMed ID: 4113511
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 57. [Primary drug resistance in adult pulmonary tuberculosis].
    Porven G; Rodriguez EJ; Piccolo R
    Medicina (B Aires); 1973; 3(6):708-15. PubMed ID: 4217868
    [No Abstract]   [Full Text] [Related]  

  • 58. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 59. The Alternative Sigma Factors SigE and SigB Are Involved in Tolerance and Persistence to Antitubercular Drugs.
    Pisu D; Provvedi R; Espinosa DM; Payan JB; Boldrin F; Palù G; Hernandez-Pando R; Manganelli R
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study of primary resistance to antitubercular agents in the Sousse region, 1981-1990].
    Benzarti M; Garrouche A; Jerray M; Hayouni A; Maalel K; Klabi N
    Tunis Med; 1996 Jan; 74(1):23-7. PubMed ID: 9507309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.